Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xenetic Biosciences (XBIO) Revenue (2023 - 2025)

Xenetic Biosciences' Revenue history spans 7 years, with the latest figure at $766296.0 for Q4 2025.

  • For Q4 2025, Revenue rose 18.11% year-over-year to $766296.0; the TTM value through Dec 2025 reached $3.0 million, up 19.04%, while the annual FY2025 figure was $3.0 million, 19.04% up from the prior year.
  • Revenue reached $766296.0 in Q4 2025 per XBIO's latest filing, down from $1.0 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.0 million in Q3 2025 to a low of $510817.0 in Q1 2024.
  • Average Revenue over 3 years is $668056.8, with a median of $631531.5 recorded in 2024.
  • The largest YoY upside for Revenue was 67.19% in 2025 against a maximum downside of 18.79% in 2025.
  • A 3-year view of Revenue shows it stood at $671963.0 in 2023, then dropped by 3.44% to $648820.0 in 2024, then increased by 18.11% to $766296.0 in 2025.
  • Per Business Quant, the three most recent readings for XBIO's Revenue are $766296.0 (Q4 2025), $1.0 million (Q3 2025), and $589897.0 (Q2 2025).